These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28562278)

  • 1. Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.
    Lind JN; Interrante JD; Ailes EC; Gilboa SM; Khan S; Frey MT; Dawson AL; Honein MA; Dowling NF; Razzaghi H; Creanga AA; Broussard CS
    Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations.
    Suarez EA; Bateman BT; Straub L; Hernández-Díaz S; Jones HE; Gray KJ; Connery HS; Davis JM; Lester B; Terplan M; Zhu Y; Vine SM; Mogun H; Huybrechts KF
    JAMA Intern Med; 2024 Mar; 184(3):242-251. PubMed ID: 38252426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.
    Nelson LF; Yocum VK; Patel KD; Qeadan F; Hsi A; Weitzen S
    JAMA Netw Open; 2020 Mar; 3(3):e201195. PubMed ID: 32186745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study.
    Bateman BT; Hernandez-Diaz S; Straub L; Zhu Y; Gray KJ; Desai RJ; Mogun H; Gautam N; Huybrechts KF
    BMJ; 2021 Feb; 372():n102. PubMed ID: 33568363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
    Wen X; Belviso N; Murray E; Lewkowitz AK; Ward KE; Meador KJ
    JAMA Netw Open; 2021 Apr; 4(4):e215708. PubMed ID: 33847750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
    Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
    Elife; 2021 Mar; 10():. PubMed ID: 33724184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis.
    Grigoriadis S; Graves L; Peer M; Mamisashvili L; Dennis CL; Vigod SN; Steiner M; Brown C; Cheung A; Dawson H; Rector N; Guenette M; Richter M
    J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31294935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
    Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
    Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
    Weston J; Bromley R; Jackson CF; Adab N; Clayton-Smith J; Greenhalgh J; Hounsome J; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010224. PubMed ID: 27819746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of topical corticosteroids in pregnancy.
    Chi CC; Wang SH; Wojnarowska F; Kirtschig G; Davies E; Bennett C
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007346. PubMed ID: 26497573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
    Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
    J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence.
    Grigoriadis S; VonderPorten EH; Mamisashvili L; Roerecke M; Rehm J; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
    J Clin Psychiatry; 2013 Apr; 74(4):e293-308. PubMed ID: 23656855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
    Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
    BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal interventions based upon fetal surveillance of the daily opioid-exposed fetus: a descriptive analysis.
    Brar B; Jackson D; Nat M; Patil P; Iriye B; Planinic P
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):909-912. PubMed ID: 30078349
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
    Zedler BK; Mann AL; Kim MM; Amick HR; Joyce AR; Murrelle EL; Jones HE
    Addiction; 2016 Dec; 111(12):2115-2128. PubMed ID: 27223595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
    Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L;
    BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.